Developing a low-cost device to quickly isolate blood cells for research
Low-Cost Platform Technology for Rapid Isolation of Peripheral Blood Mononuclear Cells
This study is testing a new, easy-to-use device that quickly separates important immune cells from a small blood sample, helping researchers work faster and more reliably on things like autoimmune diseases and vaccines.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cg Scientific, INC. NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-11077586 on NIH RePORTER |
What this research studies
This research focuses on creating a user-friendly microfluidic device that can rapidly isolate peripheral blood mononuclear cells (PBMCs) from a small blood sample. PBMCs are crucial for various scientific and clinical applications, including studies on autoimmune diseases and vaccine development. The new device aims to improve upon traditional methods that are time-consuming and often yield inconsistent results. By utilizing a patented technology, the device can isolate PBMCs in just 15 minutes, making it a valuable tool for researchers.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who require blood tests related to autoimmune diseases or other conditions that involve PBMC analysis.
Not a fit: Patients who do not have autoimmune conditions or do not require PBMC isolation for their medical care may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the efficiency and accuracy of blood cell isolation, benefiting various medical research fields.
How similar studies have performed: Previous research has shown that innovative cell isolation technologies can improve outcomes in clinical and laboratory settings, indicating a promising potential for this approach.
Where this research is happening
Worcester, United States
- Cg Scientific, INC. — Worcester, United States (Active)
Researchers
- Principal investigator: Huang, Lotien Richard — Cg Scientific, INC.
- Study coordinator: Huang, Lotien Richard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.